Literature DB >> 24585759

Protein kinase A-phosphorylated KV1 channels in PSD95 signaling complex contribute to the resting membrane potential and diameter of cerebral arteries.

Christopher L Moore1, Piper L Nelson, Nikhil K Parelkar, Nancy J Rusch, Sung W Rhee.   

Abstract

RATIONALE: Postsynaptic density-95 (PSD95) is a scaffolding protein that associates with voltage-gated, Shaker-type K(+) (KV1) channels and promotes the expression of KV1 channels in vascular smooth muscle cells of the cerebral (cVSMCs) circulation. However, the physiological role of PSD95 in mediating molecular signaling in cVSMCs is unknown.
OBJECTIVE: We explored whether a specific interaction between PSD95 and KV1 channels enables protein kinase A phosphorylation of KV1 channels in cVSMCs to promote vasodilation. METHODS AND
RESULTS: Rat cerebral arteries were used for analyses. A membrane-permeable peptide (KV1-C peptide) corresponding to the postsynaptic density-95, discs large, zonula occludens-1 binding motif in the C terminus of KV1.2α was designed as a dominant-negative peptide to disrupt the association of KV1 channels with PSD95. Application of KV1-C peptide to cannulated, pressurized cerebral arteries rapidly induced vasoconstriction and depolarized cVSMCs. These events corresponded to reduced coimmunoprecipitation of the PSD95 and KV1 proteins without altering surface expression. Middle cerebral arterioles imaged in situ through cranial window also constricted rapidly in response to local application of KV1-C peptide. Patch-clamp recordings confirmed that KV1-C peptide attenuates KV1 channel blocker (5-(4-phenylalkoxypsoralen))-sensitive current in cVSMCs. Western blots using a phospho-protein kinase A substrate antibody revealed that cerebral arteries exposed to KV1-C peptide showed markedly less phosphorylation of KV1.2α subunits. Finally, phosphatase inhibitors blunted both KV1-C peptide-mediated and protein kinase A inhibitor peptide-mediated vasoconstriction.
CONCLUSIONS: These findings provide initial evidence that protein kinase A phosphorylation of KV1 channels is enabled by a dynamic association with PSD95 in cerebral arteries and suggest that a disruption of such association may compromise cerebral vasodilation and blood flow.

Entities:  

Keywords:  PDZ domains; cerebral arteries; muscle, smooth, vascular; potassium channels

Mesh:

Substances:

Year:  2014        PMID: 24585759      PMCID: PMC4049098          DOI: 10.1161/CIRCRESAHA.114.303167

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  44 in total

1.  The glycosylation state of Kv1.2 potassium channels affects trafficking, gating, and simulated action potentials.

Authors:  Itaru Watanabe; Jing Zhu; Jhon J Sutachan; Allan Gottschalk; Esperanza Recio-Pinto; William B Thornhill
Journal:  Brain Res       Date:  2007-01-31       Impact factor: 3.252

2.  Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter.

Authors:  Frances Plane; Rosalyn Johnson; Paul Kerr; William Wiehler; Kevin Thorneloe; Kuniaki Ishii; Tim Chen; William Cole
Journal:  Circ Res       Date:  2004-12-23       Impact factor: 17.367

Review 3.  Localization and targeting of voltage-dependent ion channels in mammalian central neurons.

Authors:  Helene Vacher; Durga P Mohapatra; James S Trimmer
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

Review 4.  Postsynaptic density-membrane associated guanylate kinase proteins (PSD-MAGUKs) and their role in CNS disorders.

Authors:  F Gardoni; E Marcello; M Di Luca
Journal:  Neuroscience       Date:  2008-08-13       Impact factor: 3.590

5.  Human postsynaptic density-95 (PSD95): location of the gene (DLG4) and possible function in nonneural as well as in neural tissues.

Authors:  D G Stathakis; K B Hoover; Z You; P J Bryant
Journal:  Genomics       Date:  1997-08-15       Impact factor: 5.736

6.  Homeostatic regulation of Kv1.2 potassium channel trafficking by cyclic AMP.

Authors:  Emilee C Connors; Bryan A Ballif; Anthony D Morielli
Journal:  J Biol Chem       Date:  2007-11-14       Impact factor: 5.157

7.  Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat.

Authors:  Hong-Shuo Sun; Tracy A Doucette; Yitao Liu; Yuan Fang; Lucy Teves; Michelle Aarts; Catherine L Ryan; Paul B Bernard; Anthony Lau; Joan P Forder; Michael W Salter; Yu Tian Wang; R Andrew Tasker; Michael Tymianski
Journal:  Stroke       Date:  2008-07-10       Impact factor: 7.914

8.  Intrinsic disorder in the C-terminal domain of the Shaker voltage-activated K+ channel modulates its interaction with scaffold proteins.

Authors:  Elhanan Magidovich; Irit Orr; Deborah Fass; Uri Abdu; Ofer Yifrach
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-31       Impact factor: 11.205

9.  Trafficking-dependent phosphorylation of Kv1.2 regulates voltage-gated potassium channel cell surface expression.

Authors:  Jae-Won Yang; Helene Vacher; Kang-Sik Park; Eliana Clark; James S Trimmer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-03       Impact factor: 11.205

10.  Distinct structural requirements for clustering and immobilization of K+ channels by PSD-95.

Authors:  N A Burke; K Takimoto; D Li; W Han; S C Watkins; E S Levitan
Journal:  J Gen Physiol       Date:  1999-01       Impact factor: 4.086

View more
  14 in total

Review 1.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 2.  Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth.

Authors:  W F Jackson
Journal:  Adv Pharmacol       Date:  2016-08-17

Review 3.  β2 Adrenergic Receptor Complexes with the L-Type Ca2+ Channel CaV1.2 and AMPA-Type Glutamate Receptors: Paradigms for Pharmacological Targeting of Protein Interactions.

Authors:  Kwun Nok Mimi Man; Manuel F Navedo; Mary C Horne; Johannes W Hell
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-09-27       Impact factor: 13.820

4.  Beta1-adrenergic receptor-mediated dilation of rat cerebral artery requires Shaker-type KV1 channels on PSD95 scaffold.

Authors:  Christopher L Moore; Samantha J McClenahan; Hillary M Hanvey; Dae-Song Jang; Piper L Nelson; Biny K Joseph; Sung W Rhee
Journal:  J Cereb Blood Flow Metab       Date:  2015-05-13       Impact factor: 6.200

5.  Ser1928 phosphorylation by PKA stimulates the L-type Ca2+ channel CaV1.2 and vasoconstriction during acute hyperglycemia and diabetes.

Authors:  Matthew A Nystoriak; Madeline Nieves-Cintrón; Tommaso Patriarchi; Olivia R Buonarati; Maria Paz Prada; Stefano Morotti; Eleonora Grandi; Julia Dos Santos Fernandes; Katherine Forbush; Franz Hofmann; Kent C Sasse; John D Scott; Sean M Ward; Johannes W Hell; Manuel F Navedo
Journal:  Sci Signal       Date:  2017-01-24       Impact factor: 8.192

6.  Selective down-regulation of KV2.1 function contributes to enhanced arterial tone during diabetes.

Authors:  Madeline Nieves-Cintrón; Matthew A Nystoriak; Maria Paz Prada; Kenneth Johnson; William Fayer; Mark L Dell'Acqua; John D Scott; Manuel F Navedo
Journal:  J Biol Chem       Date:  2015-02-10       Impact factor: 5.157

7.  Dynamic Regulation of the Subunit Composition of BK Channels in Smooth Muscle.

Authors:  Gregory M Dick; Johnathan D Tune
Journal:  Circ Res       Date:  2017-09-01       Impact factor: 17.367

Review 8.  KV channels and the regulation of vascular smooth muscle tone.

Authors:  William F Jackson
Journal:  Microcirculation       Date:  2018-01       Impact factor: 2.628

Review 9.  KV channel trafficking and control of vascular tone.

Authors:  Raquibul Hasan; Jonathan H Jaggar
Journal:  Microcirculation       Date:  2018-01       Impact factor: 2.628

10.  A Gs-coupled purinergic receptor boosts Ca2+ influx and vascular contractility during diabetic hyperglycemia.

Authors:  Maria Paz Prada; Arsalan U Syed; Olivia R Buonarati; Gopireddy R Reddy; Matthew A Nystoriak; Debapriya Ghosh; Sergi Simó; Daisuke Sato; Kent C Sasse; Sean M Ward; Luis F Santana; Yang K Xiang; Johannes W Hell; Madeline Nieves-Cintrón; Manuel F Navedo
Journal:  Elife       Date:  2019-03-01       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.